Swedish StromaBio AB
Clinical stage biopharma developing MSC therapies for ARDS and Alzheimer's.
Oversigt
- 1
- Medarbejdere
- 1.5mio SEK
- Omsætning
- 2018
- Grundlagt
Beskrivelse
StromaBio AB is a clinical stage biopharma company dedicated to advancing novel cell therapies. Their core focus is developing treatments utilizing Mesenchymal Stromal Cells (MSCs) derived from bone marrow. These MSC-based products are classified as allogeneic advanced therapy medicinal products (AT...
Tags
Nøgleord
Teknologistak
Virksomhedsoplysninger
- Branche
- Medicinsk laboratorieverksamhet m.m.
- Juridisk form
- Aktiebolag
- Momsnummer
- SE559174877601
Beslutningstagere
Ingen beslutningstagere fundet endnu
Lignende virksomheder
20 lignende virksomheder i Funnelfeedr
Cellcolabs AB
68 medarbejdereScaling GMP production of high-quality mesenchymal stem cells globally.
Magle Biopharma AB
Leading stem cell focused CDMO accelerating therapeutic innovation from concept to market.
Cellcolabs Clinical AB
0 medarbejdereConducting clinical follow-up studies for stem cell treatments.
Procella Therapeutics AB
45 medarbejdereBiotech developing precision delivery platforms and advanced cell therapies.
Boost Pharma Aps Filial
0 medarbejdereDeveloping first-in-class stem cell therapy for brittle bone disease.
Udforsk mere
Spørgsmål om Swedish StromaBio AB
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo